Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 203

1.

Fecal Microbial Transplant Capsules are Safe in Hepatic Encephalopathy: A Phase 1, Randomized, Placebo-Controlled Trial.

Bajaj JS, Salzman NH, Acharya C, Sterling RK, White MB, Gavis EA, Fagan A, Hayward M, Holtz ML, Matherly S, Lee H, Osman M, Siddiqui MS, Fuchs M, Puri P, Sikaroodi M, Gillevet PM.

Hepatology. 2019 Apr 30. doi: 10.1002/hep.30690. [Epub ahead of print]

PMID:
31038755
2.

Targets to improve quality of care for patients with hepatic encephalopathy: data from a multi-centre cohort.

Bajaj JS, O'Leary JG, Tandon P, Wong F, Kamath PS, Biggins SW, Garcia-Tsao G, Lai J, Fallon MB, Thuluvath PJ, Vargas HE, Maliakkal B, Subramanian RM, Thacker LR, Reddy KR.

Aliment Pharmacol Ther. 2019 Apr 29. doi: 10.1111/apt.15265. [Epub ahead of print]

PMID:
31032966
3.

Associations between Religiosity, Spirituality, and Happiness among Adults Living with Neurological Illness.

Wade JB, Hayes RB, Wade JH, Bekenstein JW, Williams KD, Bajaj JS.

Geriatrics (Basel). 2018 Jun 23;3(3). pii: E35. doi: 10.3390/geriatrics3030035.

4.

Cholangiocyte-derived exosomal LncRNA H19 promotes hepatic stellate cell activation and cholestatic liver fibrosis.

Liu R, Li X, Zhu W, Wang Y, Zhao D, Wang X, Gurley EC, Liang G, Chen W, Lai G, Pandak WM, Lippman HR, Bajaj JS, Hylemon PB, Zhou H.

Hepatology. 2019 Apr 15. doi: 10.1002/hep.30662. [Epub ahead of print]

PMID:
30985008
5.

Manipulation of the Gut-Liver Axis Using Microbiome Restoration Therapy in Primary Sclerosing Cholangitis.

Bajaj JS, Hays RA.

Am J Gastroenterol. 2019 Mar 12. doi: 10.14309/ajg.0000000000000191. [Epub ahead of print]

PMID:
30920413
6.

Impact of Chronic Kidney Disease on Outcomes in Cirrhosis.

Wong F, Reddy KR, O'Leary JG, Tandon P, Biggins SW, Garcia-Tsao G, Maliakkal BJ, Lai JC, Fallon MB, Vargas HE, Subramanian R, Thuluvath PJ, Kamath PS, Thacker L, Bajaj JS.

Liver Transpl. 2019 Jun;25(6):870-880. doi: 10.1002/lt.25454. Epub 2019 Apr 25.

PMID:
30908855
7.

Alterations in Skin Microbiomes of Patients With Cirrhosis.

Bajaj JS, Fagan A, Sikaroodi M, Kakiyama G, Takei H, Degefu Y, Pandak WM, Hylemon PB, Fuchs M, John B, Heuman DM, Gavis E, Nittono H, Patil R, Gillevet PM.

Clin Gastroenterol Hepatol. 2019 Mar 21. pii: S1542-3565(19)30292-7. doi: 10.1016/j.cgh.2019.03.028. [Epub ahead of print]

PMID:
30905718
8.

Utility of the EncephalApp Stroop Test for covert hepatic encephalopathy screening in Chinese cirrhotic patients.

Zeng X, Li XX, Shi PM, Zhang YY, Song Y, Liu Q, Wei L, Bajaj JS, Zhu YH, Li Y, Gu Y, Xie WF, Liu YL.

J Gastroenterol Hepatol. 2019 Mar 12. doi: 10.1111/jgh.14656. [Epub ahead of print]

PMID:
30861191
9.

Specific Gut and Salivary Microbiota Patterns Are Linked With Different Cognitive Testing Strategies in Minimal Hepatic Encephalopathy.

Bajaj JS, Fagan A, White MB, Wade JB, Hylemon PB, Heuman DM, Fuchs M, John BV, Acharya C, Sikaroodi M, Gillevet PM.

Am J Gastroenterol. 2019 Jan 28. doi: 10.14309/ajg.0000000000000102. [Epub ahead of print]

PMID:
30816877
10.

Defining Acute on Chronic Liver Failure: More Elusive Than Ever.

Bajaj JS, Wong F, Kamath PS.

Hepatology. 2019 Feb 25. doi: 10.1002/hep.30589. [Epub ahead of print]

PMID:
30805952
11.

Hepatic encephalopathy and traffic accidents: Vigilance is needed!

Tapper EB, Romero-Gómez M, Bajaj JS.

J Hepatol. 2019 Apr;70(4):590-592. doi: 10.1016/j.jhep.2019.01.017. Epub 2019 Feb 11. No abstract available.

PMID:
30765121
12.

Outcomes After Listing for Liver Transplant in Patients With Acute-on-Chronic Liver Failure: The Multicenter North American Consortium for the Study of End-Stage Liver Disease Experience.

O'Leary JG, Bajaj JS, Tandon P, Biggins SW, Wong F, Kamath PS, Garcia-Tsao G, Maliakkal B, Lai J, Fallon M, Vargas HE, Thuluvath P, Subramanian R, Thacker LR, Reddy KR.

Liver Transpl. 2019 Apr;25(4):571-579. doi: 10.1002/lt.25426. Epub 2019 Mar 24.

PMID:
30724010
13.

Mitochondrial oxysterol biosynthetic pathway gives evidence for CYP7B1 as controller of regulatory oxysterols.

Kakiyama G, Marques D, Takei H, Nittono H, Erickson S, Fuchs M, Rodriguez-Agudo D, Gil G, Hylemon PB, Zhou H, Bajaj JS, Pandak WM.

J Steroid Biochem Mol Biol. 2019 May;189:36-47. doi: 10.1016/j.jsbmb.2019.01.011. Epub 2019 Jan 30.

PMID:
30710743
14.

Impact of Hepatic Encephalopathy in Cirrhosis on Quality-of-Life Issues.

Montagnese S, Bajaj JS.

Drugs. 2019 Feb;79(Suppl 1):11-16. doi: 10.1007/s40265-018-1019-y. Review.

15.

Outcomes in Patients With Cirrhosis on Primary Compared to Secondary Prophylaxis for Spontaneous Bacterial Peritonitis.

Bajaj JS, Tandon P, OʼLeary JG, Wong F, Biggins SW, Garcia-Tsao G, Kamath PS, Maliakkal B, Fallon MB, Lai JC, Thuluvath PJ, Vargas HE, Subramanian RM, Thacker LR, Reddy KR.

Am J Gastroenterol. 2019 Apr;114(4):599-606. doi: 10.14309/ajg.0000000000000044.

PMID:
30694868
16.

Long-term Outcomes of Fecal Microbiota Transplantation in Patients With Cirrhosis.

Bajaj JS, Fagan A, Gavis EA, Kassam Z, Sikaroodi M, Gillevet PM.

Gastroenterology. 2019 May;156(6):1921-1923.e3. doi: 10.1053/j.gastro.2019.01.033. Epub 2019 Jan 18. No abstract available.

PMID:
30664879
17.

Alcohol, liver disease and the gut microbiota.

Bajaj JS.

Nat Rev Gastroenterol Hepatol. 2019 Apr;16(4):235-246. doi: 10.1038/s41575-018-0099-1. Review.

PMID:
30643227
18.

Effect of Increasing Age on Brain Dysfunction in Cirrhosis.

Liu R, Ahluwalia V, Kang JD, Ghosh SS, Zhou H, Li Y, Zhao D, Gurley E, Li X, White MB, Fagan A, Lippman HR, Wade JB, Hylemon PB, Bajaj JS.

Hepatol Commun. 2018 Nov 30;3(1):63-73. doi: 10.1002/hep4.1286. eCollection 2019 Jan.

19.

Diagnosis of covert hepatic encephalopathy: a multi-center study testing the utility of single versus combined testing.

Duarte-Rojo A, Allampati S, Thacker LR, Flud CR, Patidar KR, White MB, Klair JS, Heuman DM, Wade JB, Gavis EA, Bajaj JS.

Metab Brain Dis. 2019 Feb;34(1):289-295. doi: 10.1007/s11011-018-0350-z. Epub 2018 Nov 30.

PMID:
30506333
20.

Bile Acid 7α-Dehydroxylating Gut Bacteria Secrete Antibiotics that Inhibit Clostridium difficile: Role of Secondary Bile Acids.

Kang JD, Myers CJ, Harris SC, Kakiyama G, Lee IK, Yun BS, Matsuzaki K, Furukawa M, Min HK, Bajaj JS, Zhou H, Hylemon PB.

Cell Chem Biol. 2019 Jan 17;26(1):27-34.e4. doi: 10.1016/j.chembiol.2018.10.003. Epub 2018 Oct 25.

PMID:
30482679

Supplemental Content

Loading ...
Support Center